Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 28, 2022
November 29, 2022
1c1d8e06-4c1c-4dc5-8c6a-ebfa9ce68b55
Related Documents
Human Gene Therapy for Rare Diseases: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Blood Pressure and Pulse Donor Eligibility Requirements – Compliance Policy: Guidance for Industry
Guidance DocumentJuly 17, 2024Center for Biologics Evaluation and Research
Human Gene Therapy for Hemophilia: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox